Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:576-582
Published online before print February 17, 2005, doi: 10.1161/01.RES.0000159389.55544.20
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/5/576    most recent
01.RES.0000159389.55544.20v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waeckel, L.
Right arrow Articles by Silvestre, J.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waeckel, L.
Right arrow Articles by Silvestre, J.-S.
Related Collections
Right arrow Angiogenesis
(Circulation Research. 2005;96:576.)
© 2005 American Heart Association, Inc.


Integrative Physiology

Impairment in Postischemic Neovascularization in Mice Lacking the CXC Chemokine Receptor 3

Ludovic Waeckel, Ziad Mallat, Stéphane Potteaux, Christophe Combadière, Michel Clergue, Micheline Duriez, Lu Bao, Craig Gerard, Barrett J. Rollins, Alain Tedgui, Bernard I. Levy, Jean-Sébastien Silvestre

From the INSERM U541 Hôpital Lariboisière (L.W., Z.M., S.P., M.C., M.D., A.T., B.I.L., J.-S.S.), IFR Circulation-Lariboisière, Université Paris 7-Denis Diderot, Paris, France; INSERM U543 (C.C.), Laboratoire d’immunologie cellulaire et tissulaire, Hôpital Pitié-Salpétrière, Paris, France; the Ina Sue Perlmutter Laboratory (L.B., C.G.), Children‘s Hospital, Harvard Medical School, Boston, Mass; and the Department of Medical Oncology (B.J.R.), Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Jean-Sebastien Silvestre, U541-INSERM, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris cedex 10, France. E-mail Jean-Sebastien.Silvestre{at}larib.inserm.fr

Inflammatory cell infiltration is a feature of postischemic neovascularization. However, mechanisms leading to leukocyte attraction to the site of neovascularization are still undefined. We hypothesized that the CXC chemokine receptor 3 (CXCR3) may contribute to leukocyte accumulation and subsequently to blood vessel growth in the ischemic area. Ischemia induced by femoral artery ligature improved the number of CXCR3-expressing cells and the level of its ligand, CXCL10. Angiographic score, blood flow recovery measurement, and capillary density analysis showed a significant decrease of ischemic/nonischemic leg ratio in CXCR3-deficient mice when compared with controls (P<0.05), at day 21 after ischemia. Interestingly, this impairment was as important as that observed in mice deficient for the well known CC-chemokine monocyte chemoattractant protein-1 (MCP-1). At day 7 of ischemic injury, the number of CD3-positive T cells and Mac-3–positive monocytes/macrophages was 38% and 45% lower, respectively, in the ischemic leg of CXCR3-deficient mice compared with the control group (P<0.05), suggesting an important role for CXCR3 in leukocyte recruitment into the ischemic area. VEGF protein content, a classical proangiogenic factor, was also markedly reduced (80% reduction) in ischemic leg of CXCR3-deficient mice (P<0.01). Injection of bone marrow–derived mononuclear cells (BM-MNCs) isolated from wild-type animals restored the neovascularization reaction in CXCR3-deficient mice whereas BM-MNCs from CXCR3-deficient mice was ineffective. In conclusion, CXCR3 plays a key role in neovascularization and provides novel information on the mechanisms leading to leukocyte infiltration in the vessel growth area.


Key Words: inflammation • angiogenesis • ischemia • chemokine receptor




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J.-S. Silvestre, Z. Mallat, A. Tedgui, and B. I. Levy
Post-ischaemic neovascularization and inflammation
Cardiovasc Res, May 1, 2008; 78(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva
Inflammation and ischemia-induced lung angiogenesis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Rookmaaker, M. C. Verhaar, H. C. de Boer, R. Goldschmeding, J. A. Joles, H. A. Koomans, H.-J. Grone, and T. J. Rabelink
Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F624 - F630.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. K. Shireman, V. Contreras-Shannon, O. Ochoa, B. P. Karia, J. E. Michalek, and L. M. McManus
MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration
J. Leukoc. Biol., March 1, 2007; 81(3): 775 - 785.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Waeckel, J. Bignon, J.-M. Liu, D. Markovits, T. G. Ebrahimian, J. Vilar, B. Mees, O. Blanc-Brude, V. Barateau, S. Le ricousse-Roussanne, et al.
Tetrapeptide AcSDKP Induces Postischemic Neovascularization Through Monocyte Chemoattractant Protein-1 Signaling
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Rabb
Immune Modulation of Acute Kidney Injury
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 604 - 606.
[Full Text] [PDF]